Indevus Announces Initiation of Phase III Trial of PRO 2000 (Herpes)

Indevus Announces Initiation of Phase III Trial of PRO 2000
[Press Release] Business Wire via Yahoo! Finance - Oct 25 4:09 AM
Indevus Pharmaceuticals, Inc. today announced the initiation of a large, international Phase III clinical trial of PRO 2000, the Company's topical, vaginal microbicide in development for the prevention of sexually transmitted infections, including HIV, herpes, chlamydia and gonorrhea.Save to My Web

Herpes